Chimeric Therapeutics Company
Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.
Technology:
CAR-T
Industry:
Public
Headquarters:
Carlton South, Victoria, Australia
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership